SPAC Update – January 26

– DECA announced a business combination with Longevity Biomedical
– DMYS launched tender offer at NAV, expires Feb 24
– GIA extended deadline to Feb 28 2023, $160k added to trust account
– DHHC stockholders approved deadline to July 28 2023, 30.1 million shares (87.1%) redeemed, 4.4 million shares remain, NAV $10.12
– PFDR adjourned extension vote to Feb 17
– BRLI stockholders approved deadline extension Apr 23 2023, 159k shares redeemed, 406k shares redeemed, NAV $10.77
– BIOT stockholders approved deadline extension to Oct 27 2023, 15.5 million shares (67.2%), 7.5 million shares remain, NAV $10.14
– GSQD to liquidate Feb 9, NAV $10.18
– CPTK filed DEF14a to extend deadline to Feb 11 2024, vote Feb 7, NAV $10.14
– NVAC filed S-4 for Profusa deal, no meeting date set
– GIAC / CRGO deal closed, 10.3 million shares (89.5%) redeemed, 1.2 million shares remain
– BRKH filed PRE14a to extend deadline to Sept 15 2023, vote Mar 1, NAV $10.23
– HSAQ stockholders approved Orchestra BioMed deal, closing Jan 2023
– GENQ filed DEF14a to extend deadline to Feb 17 2024, vote Feb 14, NAV $10.34
– MURF extension vote
– MSSA extension vote
– IMAQ extension vote
– ONYX extension vote
– SCMA extension vote
– CSTA extension vote
– ACAC amendment vote adjourned to Feb 8
– HSPOU split
– AACI redemption
– DTRT redemption
– LION redemption